Le Lézard
Classified in: Science and technology, Business
Subjects: ECO, CPG

Media Advisory - Ontario Auditor General to Release Report on Ministries' Performance Measurement, Program Evaluation and Annual Reporting


TORONTO, June 15, 2023 /CNW/ - On Tuesday, June 20, 2023, Auditor General Bonnie Lysyk will release the Office's Report What Gets Measured Gets Managed: Ministries' Performance Measurement, Program Evaluation and Annual Reporting. The Auditor General will be available to answer questions.

The report will be available publicly on our website at www.auditor.on.ca once it is tabled with the Legislature at approximately 10 a.m.

SOURCE Office of the Auditor General of Ontario


These press releases may also interest you

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: